Plan, rate, and provider-network data across the ACA markets – spanning more than five years of point-in-time history.
Ideon's data underpins published work in Health Affairs, JAMA Health Forum, and Health Services Research.
Structured, standardized, and longitudinal — Ideon's datasets are designed to be queried, benchmarked, and modeled, so you spend your time on findings, not data cleaning.
Benefit designs, cost-sharing, and premiums across the ACA markets.
Point-in-time provider networks across the ACA — built for adequacy and access research.
Drug coverage and formulary detail for ACA individual & family plans (IFP).
Explore, benchmark, and visualize the data without building your own pipeline.
Whether you're publishing non-commercial academic research or licensing data for applied market analysis, there's a path built for you.
Qualified, non-commercial researchers can access Ideon's benefit and premium data for the ACA individual and small group markets at no cost, through our long-standing partnership with the Robert Wood Johnson Foundation on HIX Compare.
Provider-network, formulary, and multi-market datasets — plus custom extracts and our Plan & Network Analytics platform — are available directly from Ideon for institutional and applied research. Reach out for pricing and trial access.
Researchers use Ideon's data to advance market and policy understanding. A few of the questions our data helps answer:
How do plan designs, benefits, and premiums vary and evolve across markets and years?
How broad are networks, and how does provider access differ by plan and geography?
Where do coverage options expand or contract across markets, and who is affected?
How are the ACA marketplaces shifting and what is driving it?
Tell us about your project and the markets you’re studying, and we’ll point you to the right data and access path — from the free RWJF / HIX Compare datasets to direct licensing.
For faculty, graduate researchers, and research administrators. Trial access available for qualifying non-commercial projects.